Zinda Michael 4
4 · Repare Therapeutics Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Shares
2023-01-30+24,550→ 70,591 total - Award
Employee Stock Option (right to buy)
2023-01-30+97,100→ 97,100 totalExercise: $12.42Exp: 2033-01-29→ Common Shares (97,100 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of January 30, 2024, January 30, 2025 and January 30, 2026, subject to Reporting Person continuing to provide service through each such date.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest on January 30, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.